uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects
Show others and affiliations
2012 (English)In: Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, E-ISSN 1091-6490, Vol. 109, no 2, 431-436 p.Article in journal (Refereed) Published
Abstract [en]

The multifunctional, protein cross-linking transglutaminase 2 (TG2) is the main autoantigen in celiac disease, an autoimmune disorder with defined etiology. Glutamine-rich gliadin peptides from ingested cereals, after their deamidation by TG2, induce T-lymphocyte activation accompanied by autoantibody production against TG2 in 1-2% of the population. The pathogenic role and exact binding properties of these antibodies to TG2 are still unclear. Here we show that antibodies from different celiac patients target the same conformational TG2 epitope formed by spatially close amino acids of adjacent domains. Glu153 and 154 on the first alpha-helix of the core domain and Arg19 on first alpha-helix of the N-terminal domain determine the celiac epitope that is accessible both in the closed and open conformation of TG2 and dependent on the relative position of these helices. Met659 on the C-terminal domain also can cooperate in antibody binding. This composite epitope is disease-specific, recognized by antibodies derived from celiac tissues and associated with biological effects when passively transferred from celiac mothers into their newborns. These findings suggest that celiac antibodies are produced in a surface-specific way for which certain homology of the central glutamic acid residues of the TG2 epitope with deamidated gliadin peptides could be a structural basis. Monoclonal mouse antibodies with partially overlapping epitope specificity released celiac antibodies from patient tissues and antagonized their harmful effects in cell culture experiments. Such antibodies or similar specific competitors will be useful in further functional studies and in exploring whether interference with celiac antibody actions leads to therapeutic benefits.

Place, publisher, year, edition, pages
2012. Vol. 109, no 2, 431-436 p.
Keyword [en]
conformational epitope, endomysial antibodies, immunotherapy
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-168091DOI: 10.1073/pnas.1107811108ISI: 000298950200024OAI: oai:DiVA.org:uu-168091DiVA: diva2:492469
Available from: 2012-02-08 Created: 2012-02-06 Last updated: 2012-02-08Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Dahlbom, Ingrid
By organisation
In the same journal
Proceedings of the National Academy of Sciences of the United States of America
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 173 hits
ReferencesLink to record
Permanent link

Direct link